A hypomorphic myogenin allele reveals distinct myogenin expression levels required for viability, skeletal muscle development, and sternum formation

Developmental Biology

Volumn 208, Issue 1, 1999, Pages 44-55

  Vivian, Jay L ^a   Gan, Lin ^a   Olson, Eric N ^b   Klein, William H ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

bHLH proteins; Muscle specific gene expression; Myogenin; Skeletal muscle differentiation

Indexed keywords

HELIX LOOP HELIX PROTEIN; MYOGENIN; TRANSCRIPTION FACTOR;

ARTICLE; DNA TRANSCRIPTION; FETUS DEVELOPMENT; GENE EXPRESSION SYSTEM; GENOTYPE; HYPOPLASIA; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

MAMMALIA;

EID: 0033121066     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1998.9182     Document Type: Article

References (30)

1. Arnold, H.-H., and Braun, T. (1993). Myogenic control genes in vertebrates. In "Advances in Developmental Biology" (P. M. Wasserman, Ed.), pp. 111-158. JAI Press, Greenwich.
2. Arnold, H.-H., and Braun, T. (1996). Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: A review. Int. J. Dev. Biol. 40, 345-363.
3. Braun, T., Rudnicki, M. A., Arnold, H.-H., and Jaenisch, R. (1992). Targeted inactivation of the mouse regulatory gene myf5 results in abnormal rib development and perinatal death. Cell 71, 369-382.
4. Cheng, T. C., Tseng, B. S., Merlie, J. P., Klein, W. H., and Olson, E. N. (1995). Activation of the myogenin promoter during mouse embryogenesis in the absence of positive autoregulation. Proc. Natl. Acad. Sci. USA 92, 561-565.
5. Chevallier, A. (1975). Role du mesoderme somitique dans le developpement de la cage thoracique de l'embryon d'oiseau. I. Origine du segment sternal et mecanismes de la differenciation des cotes. J. Embryol. Exp. Morphol. 33, 291-311.
6. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162, 156-159.
7. Edmondson, D. G., Cheng, T. C., Cserjesi, P., Chakraborty, T., and Olson, E. N. (1992). Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol. Cell. Biol. 12, 3665-3677.
8. Grass, S., Arnold, H.-H., and Braun, T. (1996). Alterations in somite patterning of Myf-5-deficient mice: A possible role for FGF-4 and FGF-6. Development 122, 141-150.
9. Hasty, P., Bradley, A., Morris, J. H., Venuti, J. M., Edmondson, D. G., Oison, E. N., and Klein, W. H. (1993). Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364, 501-506.
10. Hollenberg, S. M., Cheng, P. F., and Weintraub, H. (1993). Use of a conditional MyoD transcription factor in studies of MyoD transactivation and muscle determination. Proc. Natl. Acad. Sci. USA 90, 8028-8032.
11. Kato, N., and Aoyama, H. (1998). Dermomyotomal origin of the ribs as revealed by extirpation and transplantation experiments in chick and quail embryos. Development 125, 3437-3443.
12. Lin, Q., Schwarz, J., Bucana, C., and Olson, E. H. (1997). Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276, 1404-1407.
13. McLeod, M. J. (1980). Differential staining of cartilage and bone in whole mouse fetuses by Alcian blue and Alizarin red S. Teratology 22, 299-301.
14. McMahon, A. P., and Bradley, A. (1990). The Wnt-1 (int-1) protooncogene is required for development of a large region of the mouse brain. Cell 62, 1073-1085.
15. Molkentin, J. D., Black, B. L., Martin, J. F., and Olson, E. N. (1995). Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83, 1125-1136.
16. Molkentin, J. D., and Olson, E. N. (1996). Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 93, 9366-9373.
17. Myer, A., Wagner, D. S., Vivian, J. L., Olson, E. N., and Klein, W. H. (1997). Wild-type myoblasts rescue the ability of myogenin-null myoblasts to fuse in vivo. Dev. Biol. 185, 127-138.
18. Nabeshima, Y. K., Hanoka, K., Hayasaka, M., Esumi, S., Li, S., and Nonaka, I. (1993). Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364, 532-535.
19. Olson, E. N. (1990). The MyoD family: A paradigm for development? Genes Dev. 4, 1454-1461.
20. Olson, E. N., Arnold, H.-H., Rigby, P. W. J., and Wold, B. J. (1996). Know your neighbors: Three phenotypes in null mutations of the myogenic bHLH gene MRF4. Cell 85, 1-4.
21. Patapoutian, A., Yoon, J. K., Miner, J. H., Wang, S., Stark, K., and Wold, B. (1995). Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. Development 121, 3347-3358.
22. Rawls, A., Morris, J. H., Rudnicki, M., Braun, T., Arnold, H.-H., Klein, W. H., and Olson, E. N. (1995). Myogenin's functions do not overlap with those of MyoD or Myf5 during mouse embryogenesis. Dev. Biol. 172, 37-50.
23. Rawls, A., Valdez, M. R., Zhang, W., Richardson, J., Klein, W. H., and Olson, E. N. (1998). Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice. Development 125, 2349-2358.
24. Rudnicki, M. A., Braun, T., Hinuma, S., and Jaenisch, R. (1992). Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71, 383-390.
25. Rudnicki, M. A., Schnegelsberg, P. N. J., Stead, R. H., Braun, T., Arnold, H.-H., and Jaenisch, R. (1993). myoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359.
26. Venuti, J. M., Morris, J. H., Vivian, J. L., Olson, E. N., and Klein, W. H. (1995). Myogenin is required for late but not early aspects of myogenesis during mouse development. J. Cell Biol. 128, 563-576.
27. Vincent, S., Marty, L., and Fort, P. (1993). S26 ribosomal protein RNA: An invariant control for gene regulation experiments in eucaryotic cells and tissues. Nucleic Acids Res. 21, 1498.
28. Wang, Y., and Jaenisch, R. (1997). Myogenin can substitute for Myf5 in promoting myogenesis but less efficiently. Development 124, 2507-2513.
29. Wang, Y., Schnegelsberg, P. N. J., Dausman, J., and Jaenisch, R. (1996). Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Nature 379, 823-825.
30. Yun, K., and Wold, B. (1996). Skeletal muscle determination and differentiation: A story of a core regulatory network and its context. Curr. Opin. Cell Biol 8, 877-889.